Cox Troy
SEC Form 4 insider trading activity
Cox Troy has filed 5 SEC Form 4 filings (5 transaction rows) across 3 companies, including MPLT, LAB, SOPH, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.
On the most recent filing, Cox Troy is listed as Director at MapLight Therapeutics, Inc. Inside the rolling window, Cox Troy reported 1 open-market purchase totaling $149K in MPLT and no open-market sales.
Companies traded
Other insiders at MPLT
Insider Buying
$149K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cox Troy made?
Cox Troy has filed 5 SEC Form 4 filings (5 transaction rows) across 3 companies, including MPLT, LAB, SOPH since 2026.
Which companies does Cox Troy trade?
Cox Troy has filed SEC Form 4 disclosures for 3 companies, including MPLT, LAB, SOPH.
When was Cox Troy's most recent SEC Form 4 filing?
Cox Troy's most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.
What is Cox Troy's total buy and sell value in the current window?
Inside the rolling retention window, Cox Troy bought $149K and sold $0 based on SEC Form 4 filings.
What was Cox Troy's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 15,620 MPLT shares on 2026-07-28, worth $149K, per SEC Form 4 filings.